BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26062048)

  • 1. I. Hodgkin lymphoma: special challenges and solutions.
    Connors JM
    Hematol Oncol; 2015 Jun; 33 Suppl 1():21-4. PubMed ID: 26062048
    [No Abstract]   [Full Text] [Related]  

  • 2. Hodgkin lymphoma in Africa: present and future.
    Stefan DC
    Transfus Apher Sci; 2013 Oct; 49(2):144-6. PubMed ID: 23953134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hodgkin lymphoma (Hodgkin disease)].
    Naumann UK; Käser L; Vetter W
    Praxis (Bern 1994); 2006 Nov; 95(44):1697-703; quiz 1704, 1706. PubMed ID: 17111877
    [No Abstract]   [Full Text] [Related]  

  • 4. XVIII. Management of nodular lymphocyte predominant Hodgkin lymphoma.
    Advani RH; Hoppe RT
    Hematol Oncol; 2015 Jun; 33 Suppl 1():90-5. PubMed ID: 26062064
    [No Abstract]   [Full Text] [Related]  

  • 5. [Changing patterns in the clinical, pathological features of Hodgkin lymphoma].
    Miltényi Z; Simon Z; Páyer E; Váróczy L; Gergely L; Jóna A; Illés A
    Orv Hetil; 2010 Dec; 151(49):2011-8. PubMed ID: 21106481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Hodgkin lymphoma: a 50-year perspective.
    Canellos GP; Rosenberg SA; Friedberg JW; Lister TA; Devita VT
    J Clin Oncol; 2014 Jan; 32(3):163-8. PubMed ID: 24441526
    [No Abstract]   [Full Text] [Related]  

  • 7. XVII. Treatment of advanced-stage Hodgkin lymphoma.
    Engert A
    Hematol Oncol; 2015 Jun; 33 Suppl 1():87-9. PubMed ID: 26062063
    [No Abstract]   [Full Text] [Related]  

  • 8. XVI. Early stage Hodgkin lymphoma.
    Radford J
    Hematol Oncol; 2015 Jun; 33 Suppl 1():84-6. PubMed ID: 26062062
    [No Abstract]   [Full Text] [Related]  

  • 9. Nasopharyngeal Hodgkin lymphoma.
    Johnson ME; Robu VG; Turaka A
    J Clin Oncol; 2014 Apr; 32(11):e40-1. PubMed ID: 24449240
    [No Abstract]   [Full Text] [Related]  

  • 10. Intracerebral progression of Hodgkin lymphoma in a man with HIV.
    Saloura V; Grivas PD; Mapow D; Kazmi K; Ward K; Styler M
    Postgrad Med; 2009 Nov; 121(6):170-5. PubMed ID: 19940428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis and treatment of nodular lymphocyte predominant Hodgkin lymphoma].
    Nagai H
    Nihon Rinsho; 2012 Apr; 70 Suppl 2():561-7. PubMed ID: 23134016
    [No Abstract]   [Full Text] [Related]  

  • 12. [Primarily detected lymphogranulomatosis].
    Ardashev VN; Kizhaev EV; Zav'ialov MS
    Voen Med Zh; 2000 Feb; 321(2):41-8. PubMed ID: 10870447
    [No Abstract]   [Full Text] [Related]  

  • 13. [Malignant lymphoma in pediatrics].
    Ise T
    Rinsho Hoshasen; 1985 Oct; 30(11):1415-25. PubMed ID: 3910879
    [No Abstract]   [Full Text] [Related]  

  • 14. Hodgkin lymphoma and the impact of age.
    Armitage JO
    Oncology (Williston Park); 2008 Nov; 22(12):1379, 1385. PubMed ID: 19322947
    [No Abstract]   [Full Text] [Related]  

  • 15. Hodgkin disease/lymphoma.
    Hoppe RT; Advani RH; Ambinder RF; Bierman PJ; Bloomfield CD; Blum K; Dabaja B; Djulbegovic B; Forero A; Gordon LI; Hernandez-Ilizaliturri FJ; Hudson MM; Kaminski MS; Love G; Maloney DG; Mansur D; Mauch PM; Moore JO; Schilder RJ; Weiss LM; Winter JN; Yahalom J; Zelenetz AD;
    J Natl Compr Canc Netw; 2008 Jul; 6(6):594-622. PubMed ID: 18597713
    [No Abstract]   [Full Text] [Related]  

  • 16. T-cell/histiocyte-rich large B-cell lymphoma--transformation of nodular lymphocyte predominant Hodgkin lymphoma in the bone marrow.
    Eyre TA; King AJ; Hatton C; Collins GP
    Eur J Haematol; 2014 Jun; 92(6):550-1. PubMed ID: 24483596
    [No Abstract]   [Full Text] [Related]  

  • 17. [Malignant lymphoma in children].
    Leverger G; Frappaz D; Patte C; Philip T
    Rev Prat; 1993 Nov; 43(17):2177-81. PubMed ID: 8146532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developments in the management of Hodgkin's lymphoma.
    Lowry L; Hoskin P; Linch D
    Lancet; 2010 Mar; 375(9717):786-8. PubMed ID: 20171729
    [No Abstract]   [Full Text] [Related]  

  • 19. Hodgkin's and non-Hodgkin's lymphomas.
    McElwain TJ
    Br J Hosp Med; 1984 Jan; 31(1):10-4, 18-9. PubMed ID: 6697038
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinically relevant prognostic factors in malignant lymphoma].
    Engelhard M; Löffler M
    Internist (Berl); 1993 Feb; 34(2):127-31. PubMed ID: 8454425
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.